BITK

Enhance and optimize the "Be in the Know about OCS" program to help HCPs recognize OCS use as a sign of uncontrolled asthma and prescribe DUPIXENT sooner. According to GINA, maintenance OCS should be avoided and OCS bursts reserved as a last resort for exacerbations. Partnering with Steritas, we show the not-so-hidden costs of OCS overuse, when an emergency, systemic treatment is prescribed for long term symptom management. DUPIXENT offers a targeted approach, reducing and eliminating OCS use.We want to inspire HCPs to identify uncontrolled asthma 
more often and more easily so they move more quickly to DUPIXENT.